Similar articles

• Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.

  Shimoyama M, Kawai M, Nasu S, Shioji K, Hoshi Y. Shimoyama M, et al. Physiol Chem Phys. 1975;7(2):125-32. Physiol Chem Phys. 1975. PMID: 239431
• Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].

  Saeed SA, Butt NM, Lovely JR, Collier HO. Saeed SA, et al. Biochem Soc Trans. 1979 Oct;7(5):1042-4. doi: 10.1042/bst0071042. Biochem Soc Trans. 1979. PMID: 229022 No abstract available.
• Metabolism of adenosine-3', 5'-cyclic monophosphate in the liver of rats treated with nicotinamide.

  Lusini P, Ricci C. Lusini P, et al. Ital J Biochem. 1983 May-Jun;32(3):152-60. Ital J Biochem. 1983. PMID: 6317608
• Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors.

  Shepherd MC. Shepherd MC. Pulm Pharmacol Ther. 2006;19(1):24-31. doi: 10.1016/j.pupt.2005.05.002. Epub 2005 Jul 20. Pulm Pharmacol Ther. 2006. PMID: 16046159 Review. No abstract available.
• Increased building block access through collaboration.

  Helal CJ, Bartolozzi A, Goble SD, Mani NS, Guzman-Perez A, Ohri AK, Shi ZC, Subramanyam C. Helal CJ, et al. Drug Discov Today. 2018 Aug;23(8):1458-1462. doi: 10.1016/j.drudis.2018.03.001. Epub 2018 Mar 20. Drug Discov Today. 2018. PMID: 29571837 Review. No abstract available.